BlackRock’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Buy
225,046
+15,467
+7% +$33.7K ﹤0.01% 4563
2025
Q4
$675K Buy
209,579
+93,395
+80% +$249K ﹤0.01% 4412
2025
Q3
$206K Buy
116,184
+3,677
+3% +$6.2K ﹤0.01% 4676
2025
Q2
$203K Buy
112,507
+28,100
+33% +$52K ﹤0.01% 4670
2025
Q1
$161K Sell
84,407
-1,654
-2% -$3.67K ﹤0.01% 4643
2024
Q4
$186K Buy
86,061
+1,137
+1% +$2.28K ﹤0.01% 4634
2024
Q3
$151K Buy
84,924
+304
+0.4% +$382 ﹤0.01% 4588
2024
Q2
$108K Buy
84,620
+9,222
+12% +$23.9K ﹤0.01% 4684
2024
Q1
$284K Buy
75,398
+47,787
+173% +$198K ﹤0.01% 4517
2023
Q4
$90.2K Sell
27,611
-314
-1% -$873 ﹤0.01% 4834
2023
Q3
$91.6K Sell
27,925
-1,099
-4% -$4.17K ﹤0.01% 4869
2023
Q2
$130K Buy
29,024
+4,246
+17% +$20.7K ﹤0.01% 4840
2023
Q1
$119K Sell
24,778
-202
-0.8% -$826 ﹤0.01% 4917
2022
Q4
$78.2K Buy
24,980
+2,079
+9% +$6.5K ﹤0.01% 5116
2022
Q3
$75K Sell
22,901
-640
-3% -$2.4K ﹤0.01% 5260
2022
Q2
$85K Buy
23,541
+12,904
+121% +$44.5K ﹤0.01% 5277
2022
Q1
$43K Sell
10,637
-522
-5% -$2.18K ﹤0.01% 5442
2021
Q4
$60K Sell
11,159
-317
-3% -$2.19K ﹤0.01% 5377
2021
Q3
$85K Sell
11,476
-183
-2% -$1.53K ﹤0.01% 5176
2021
Q2
$116K Buy
+11,659
New +$131K ﹤0.01% 5009

Other funds holding GANX